Cancer Treatment Centers of America® (CTCA), a national network of comprehensive cancer care hospitals and outpatient care centers, and Foundation Medicine, a leading molecular insights company that recently received FDA approval for its FoundationOne CDx™ genomic test, today announced the launch of a collaborative educational campaign designed to heighten awareness of the promise of precision medicine and the role that advanced genomic testing plays in helping identify treatments best suited for individual patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8295651-cancer-treatment-centers-of-america-foundation-medicine-precision-cancer-treatment/
DocuSign, Inc. (DocuSign®) launched its DocuSign Winter ’15 Release, which includes an improved signing experience based on customer feedback from focus groups, usability studies, user testing and more. DocuSign’s new signing experience features both visual and interaction design enhancements that reflect the company’s commitment to customer-centric product innovation, www.docusign.com/docusign-winter-15-release.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7312253-docusign-winter-15/
Kelley Blue Book www.kbb.com, the vehicle valuation and information source trusted and relied upon by both consumers and the automotive industry, today announces the winners of the 2017 Kelley Blue Book Best Buy Awards, honoring the top new model-year vehicle choices available in the U.S. market. The 2017 Honda Civic is named Kelley Blue Book’s Overall Best Buy of 2017, alongside Best Buy Award winners in 12 major vehicle categories.
The Kelley Blue Book Best Buy Awards are designed to provide a significant service to new-car buyers by identifying the cream of the crop of all available 2017 model-year vehicles. The awards are the culmination of a year-long regimen of expert vehicle evaluation and testing of nearly every new vehicle available in America, along with analysis of a broad swath of vehicle-related data, including vehicle pricing/transaction prices, 5-Year Cost to Own data (which includes depreciation, insurance, maintenance, financing, fuel, fees and taxes for new cars), consumer reviews and ratings, and vehicle sales/retail sales information. Of more than 300 new-car models available for 2017, Kelley Blue Book’s expert editors initially narrowed the field to a few dozen Best Buy Award contenders in 12 major vehicle categories and then spent several weeks testing and evaluating all of the finalists head-to-head to ultimately determine the winners.
To view the multimedia release go to:
http://www.multivu.com/players/English/7952451-kelley-blue-book-2017-best-buy-awards/
REMBRANDT®, the original at-home teeth whitening brand, enters the power toothbrush market for the first time with the launch of its power Whitening Toothbrush and Whitening Brush Heads, rounding out the brand’s suite of highly effective, scientifically proven teeth whitening solutions. The power toothbrush and 3-pack of replacement brush heads are now available online at Amazon.com and Rembrandt.com with a suggested retail price of $59.99 and $19.99 each, respectively.
REMBRANDT’S unique design features two brushing modes—Whitening and Sensitive—to allow consumers the ability to customize their daily whitening experience.
Based on in vitro laboratory testing, the REMBRANDT® Whitening Toothbrush and Brush Heads demonstrated seven times more plaque removal compared to a manual toothbrush. The rechargeable handle features a two-minute timer and a pressure sensor indicator to alert the user if they’re brushing too hard.
To view the multimedia release go to:
https://www.multivu.com/players/English/8240751-rembrandt-whitening-power-toothbrush/
Today, Church & Dwight, Co., Inc., the makers of First Response™ pregnancy and ovulation tests, announced the launch of First Response™ Pregnancy PRO Digital Pregnancy Test & App Access – their latest innovation and the first and only Bluetooth Smart-enabled pregnancy test on the market. First Response™ Pregnancy PRO connects to a woman’s smart device through a mobile application. Once synced, the app provides her with pregnancy-related content only available with Pregnancy PRO, and delivers a personalized user experience throughout her entire pregnancy journey.
“We are thrilled to be unveiling the next generation of in-home pregnancy testing on a stage like CES, where so many technological advancements have made their debut,” said Stacey Feldman, Vice President of Marketing, Church & Dwight. “With Pregnancy PRO, we’ve leveraged unique consumer insights to develop a product that not only revolutionizes the pregnancy test category, but more importantly, provides women with the information they need during their journey.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7725251-first-response-pregnancy-pro/
Kelley Blue Book www.kbb.com, the only vehicle valuation and information source trusted and relied upon by both consumers and the automotive industry, today announces the winners of the 2016 Kelley Blue Book Best Buy Awards, honoring the top new model-year vehicle choices available in the U.S. market. The 2016 Honda Civic is named Kelley Blue Book’s Overall Best Buy of 2016, alongside Best Buy Award winners in 12 major vehicle categories.
“After carefully analyzing a wealth of data and conducting extensive vehicle testing and evaluation from the hundreds of models available for the 2016 model-year, we chose this year’s elite group of 12 Kelley Blue Book Best Buy Award winners because they proved to be the top values in their class,” said Jack R. Nerad, executive editorial director and executive market analyst for Kelley Blue Book’s KBB.com. “Our group of expert vehicle testers chose the totally redesigned 2016 Honda Civic as the Overall Winner in our Best Buy Awards because it sets a new standard in a segment already known for delivering great value, providing an up-level experience to drivers and passengers in every facet of the driving and ownership experience.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7641651-kbb-2016-best-buy-awards/
Today, the newly-developed Body Volume Indicator (BVI)™ was revealed as a modern day measure of body composition and weight distribution following a 10-year collaboration with Mayo Clinic experts who led extensive research on fat distribution, the importance of fat assessment and the limitations of the current standard of Body Mass Index (BMI). In conjunction with the development of BVI, BVI America LLC, a subsidiary of 3D measurement pioneer Select Research, announced the launch of the revolutionary BVI Pro tablet application, which will provide an easily accessible and affordable means for the professional community to use the new BVI measurement in everyday clinical use to assess health risks.
The potential benefits of using Body Volume as a new indicator of risks were presented on April 27 by Mayo Clinic researchers, BVI America and the University of Westminster. It draws on 10 years of rigorous research, testing and validation using several potential Body Volume indices. Now BVI, calculated as a ratio between total volume and abdominal volume, can be used as a supplement to the current measurement standard of BMI, which is based solely on height and weight. BVI is considered to be a more precise means of estimating weight distribution and the fat around the organs, which is not visible to the human eye and can lead to serious health conditions, such as diabetes and heart disease. The medical and professional community at large is invited to contribute to the continued development of BVI by downloading and using the BVI Pro tablet application with their patients and clients; anonymous data collected will be analyzed by Mayo Clinic, whose research and validation of BVI will continue.
To view the multimedia release go to:
https://www.multivu.com/players/English/8093051-bvi-america-body-volume-app-health-fitness/
BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology.
BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
